Effectiveness and Safety of Regdanvimab in Patients With Mild-To-Moderate COVID-19: A Retrospective Cohort Study
Park et al., Journal of Korean Medical Science, doi:10.3346/jkms.2022.37.e102
https://c19early.org/park5.html